CrossBay Medical

CrossBay Medical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

CrossBay Medical is a private, commercial-stage medical device company pioneering a platform technology for uterine access. Its core innovation, CrossGlide™, is a self-guiding technology that allows for atraumatic crossing of the cervix, aiming to eliminate the need for painful tenaculum use and reduce the risk of uterine perforation. The company has successfully secured FDA and CE clearances, licensed its technology to major players like Vitrolife and Hologic, and is now focused on commercializing its own suite of products for office-based gynecological care. CrossBay targets a large market of common, often painful procedures such as endometrial biopsy, IUD placement, and hysteroscopy.

Women's Health

Technology Platform

CrossGlide™: A self-guided, frictionless technology platform for atraumatic access across the cervix and into the uterine cavity, eliminating the need for a tenaculum and reducing patient pain and procedural risk.

Opportunities

The large, underserved market for common office-based gynecological procedures (biopsy, IUD placement, hysteroscopy) presents a multi-billion dollar opportunity.
Growing emphasis on pain management and in-office care creates strong tailwinds for technologies that improve patient experience and procedural efficiency.

Risk Factors

Key risks include the challenge of commercializing devices directly after a history of licensing, potential competition from large established medtech companies, and the need to drive widespread clinical adoption and secure favorable reimbursement for the new technology platform.

Competitive Landscape

Competitors include makers of traditional gynecological devices (e.g., CooperSurgical's Pipelle, various IUD inserters, rigid dilators). CrossBay's primary differentiation is its self-guiding, atraumatic platform. It may also face future competition from other innovative startups or large companies developing less painful cervical access technologies.